Chemoinformaics analysis of Glaucarubol 15-O-beta-D-glucopyranoside
| Molecular Weight | 558.577 | nRot | 3 |
| Heavy Atom Molecular Weight | 520.273 | nRig | 30 |
| Exact Molecular Weight | 558.231 | nRing | 6 |
| Solubility: LogS | -1.82 | nHRing | 3 |
| Solubility: LogP | -1.454 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 39 | No. of Aromatic Carbocycles | 0 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 0 |
| nHA | 13 | APOL | 79.1841 |
| nHD | 8 | BPOL | 45.9339 |
| QED | 0.126 |
| Synth | 6.89 |
| Natural Product Likeliness | 3.732 |
| NR-PPAR-gamma | 0.056 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.988 |
| HIA | 0.981 |
| CACO-2 | -6.241 |
| MDCK | 0.000276322 |
| BBB | 0.101 |
| PPB | 0.296548 |
| VDSS | 0.368 |
| FU | 0.488749 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.096 |
| CYP2c19-inh | 0.001 |
| CYP2c19-sub | 0.133 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.077 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.116 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.024 |
| CL | 1.173 |
| T12 | 0.112 |
| hERG | 0.005 |
| Ames | 0.147 |
| ROA | 0.168 |
| SkinSen | 0.005 |
| Carcinogencity | 0.013 |
| EI | 0.003 |
| Respiratory | 0.102 |
| NR-Aromatase | 0.016 |
| Antiviral | Yes |
| Prediction | 0.803123 |